The BMO Pharmaceuticals & Healthcare Service A data and intelligence tool providing global pharmaceuticals and healthcare sector analysis, forecasts, and an assessment of company activity and sector trends worldwide
Key Benefits
- Identify business growth opportunities globally
- Support the generation and review of business strategy
- Monitor competitors, clients and suppliers
- Evaluate risk and opportunities
Free Trial
Country Markets Covered...
Africa
Algeria, Egypt, Ghana, Kenya, Morocco, Nigeria, South Africa, Zimbabwe
Asia Pacific
Australia, Bangladesh, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Vietnam
Caribbean
Belize, Cuba, Puerto Rico
Europe
Belarus, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Luxembourg, Moldova, Netherlands, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, Uzbekistan
Latin America
Argentina, Brazil, Chile, Colombia, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Peru, Venezuela
Midde East
Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
North America
Canada and United States
The BMO Pharmaceuticals & Healthcare Service is successfully utilised by the following:
- Drug and medical devices manufacturers
- Retailers and wholesalers
- CRO's and CMO's
- Suppliers
- Policy makers
- Regulators and associations
- Decision-makers across financial and professional services
Key features across the prescription, patented, OTC, generics, medical devices, healthcare and R&D sectors:
- Daily News Analysis providing intelligence and views on market developments, the regulatory environment, company results and strategy worldwide
- Risk-Reward Ratings providing a country-comparative assessment of the market potential and operational risks facing the pharmaceuticals and healthcare industries in each state
- Comprehensive Market Assessments and 5- and 10-year Forecasts produced every quarter for 80 countries in the sector that account for over 95% of global pharmaceuticals expenditure
- Interactive Database consisting of historic data and forecasts for over 150 industry indicators in each state
- Burden of Disease Database measuring the impact of over 120 diseases on a country, gender and age specific level until 2030
- Competitive Intelligence and Company SWOT Analysis, providing a visual snapshot of the competitive landscape and detailed SWOT analyses of the leading multinational and domestic players